Should we use total mortality rather than cancer specific mortality to judge cancer screening programmes? Yes
Author:
Abstract
James Penston believes all cause mortality is a more reliable measure of the effectiveness of screening, but Robert Steele and David Brewster (doi:10.1136/bmj.d6397) think it is too stringentKeywords
This publication has 7 references indexed in Scilit:
- The Breast Screening Programme and misinforming the publicJournal of the Royal Society of Medicine, 2011
- Screening for Breast and Prostate Cancers: Moving Toward TransparencyJNCI: Journal of the National Cancer Institute, 2010
- Cochrane Systematic Review of Colorectal Cancer Screening Using the Fecal Occult Blood Test (Hemoccult): An UpdateAmerican Journal of Gastroenterology, 2008
- Does Fecal Occult Blood Testing Really Reduce Mortality? A Reanalysis of Systematic Review DataAmerican Journal of Gastroenterology, 2006
- All-cause mortality among breast cancer patients in a screening trial: support for breast cancer mortality as an end pointJournal of Medical Screening, 2002
- Effect of faecal occult blood screening on mortality from colorectal cancer: results from a randomised controlled trialGut, 2002
- All-Cause Mortality in Randomized Trials of Cancer ScreeningJNCI: Journal of the National Cancer Institute, 2002